Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patient-Derived Models of Cancer in the NCI PDMC Consortium: Selection, Pitfalls, and Practical Recommendations.
Habowski AN, Budagavi DP, Scherer SD, Aurora AB, Caligiuri G, Flynn WF, Langer EM, Brody JR, Sears RC, Foggetti G, Arnal Estape A, Nguyen DX, Politi KA, Shen X, Hsu DS, Peehl DM, Kurhanewicz J, Sriram R, Suarez M, Xiao S, Du Y, Li XN, Navone NM, Labanca E, Willey CD. Habowski AN, et al. Among authors: brody jr. Cancers (Basel). 2024 Jan 29;16(3):565. doi: 10.3390/cancers16030565. Cancers (Basel). 2024. PMID: 38339316 Free PMC article. Review.
Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor Microenvironment.
Shah VM, Rizvi S, Smith A, Tsuda M, Krieger M, Pelz C, MacPherson K, Eng J, Chin K, Munks MW, Daniel CJ, Al-Fatease A, Yardimci GG, Langer EM, Brody JR, Sheppard BC, Alani AW, Sears RC. Shah VM, et al. Among authors: brody jr. Pharmaceutics. 2023 Nov 21;15(12):2651. doi: 10.3390/pharmaceutics15122651. Pharmaceutics. 2023. PMID: 38139993 Free PMC article.
IDH1 inhibition potentiates chemotherapy efficacy in pancreatic cancer.
Zarei M, Hajihassani O, Hue JJ, Loftus AW, J Graor H, Nakazzi F, Naji P, Boutros CS, Uppin V, Vaziri-Gohar A, Shalaby A, Asara JM, Rothermel LD, Brody JR, Winter JM. Zarei M, et al. Among authors: brody jr. Cancer Res. 2024 Jun 6. doi: 10.1158/0008-5472.CAN-23-1895. Online ahead of print. Cancer Res. 2024. PMID: 38843355
Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase I clinical trial in early-stage pancreatic ductal adenocarcinoma.
Ponzini FM, Schultz CW, Leiby BE, Cannaday S, Yeo T, Posey J, Bowne WB, Yeo C, Brody JR, Lavu H, Nevler A. Ponzini FM, et al. Among authors: brody jr. BMJ Open. 2023 Oct 17;13(10):e073839. doi: 10.1136/bmjopen-2023-073839. BMJ Open. 2023. PMID: 37848297 Free PMC article.
Targeting the RNA-Binding Protein HuR in Cancer.
Finan JM, Sutton TL, Dixon DA, Brody JR. Finan JM, et al. Among authors: brody jr. Cancer Res. 2023 Nov 1;83(21):3507-3516. doi: 10.1158/0008-5472.CAN-23-0972. Cancer Res. 2023. PMID: 37683260 Review.
Increased glucose availability sensitizes pancreatic cancer to chemotherapy.
Vaziri-Gohar A, Hue JJ, Abbas A, Graor HJ, Hajihassani O, Zarei M, Titomihelakis G, Feczko J, Rathore M, Chelstowska S, Loftus AW, Wang R, Zarei M, Goudarzi M, Zhang R, Willard B, Zhang L, Kresak A, Willis JE, Wang GM, Tatsuoka C, Salvino JM, Bederman I, Brunengraber H, Lyssiotis CA, Brody JR, Winter JM. Vaziri-Gohar A, et al. Among authors: brody jr. Nat Commun. 2023 Jun 28;14(1):3823. doi: 10.1038/s41467-023-38921-8. Nat Commun. 2023. PMID: 37380658 Free PMC article.
A Novel 3DNA® Nanocarrier effectively delivers payloads to pancreatic tumors.
McCarthy GA, Jain A, Di Niro R, Schultz CW, Jiang W, Yeo CJ, Bowers J, Finan J, Rhodes K, Casta L, Hou V, Stefanoni A, Brown SZ, Nevler A, Agostini LC, Getts L, Getts R, Brody JR. McCarthy GA, et al. Among authors: brody jr. Transl Oncol. 2023 Jun;32:101662. doi: 10.1016/j.tranon.2023.101662. Epub 2023 Mar 31. Transl Oncol. 2023. PMID: 37004490 Free PMC article.
169 results